A5103040926- Advanced Glycation End Products research
- Autophagy in Disease and Therapy
- Phagocytosis and Immune Regulation
- Asthma and respiratory diseases
- Respiratory and Cough-Related Research
- Pediatric health and respiratory diseases
- Cannabis and Cannabinoid Research
Central South University
2024
Tongji University
2023
Tongji Hospital
2023
Shanghai Jiao Tong University
2019
Ruijin Hospital
2019
1. GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden Study 2017. Lancet Respir Med. 2020;8(6):585-596. doi:10.1016/S2213-2600(20)30105-3 CrossRef Google Scholar
Only limited studies have depicted the unique features and management of refractory chronic cough (RCC) unexplained (UCC). These led to initiation this study, which reported demographic characteristics, manifestations, long-term outcomes on a large series consecutive RCC/UCC patients, providing guideline-led real-world clinical experience.Retrospective baseline information was obtained from Clinical Research Database (January 2016 May 2021). At least 6 months after last clinic visit,...
Leukotriene B4 (LTB4) is a major pro-inflammatory mediator that leads to the persistence of chronic inflammation in obstructive pulmonary disease (COPD). The purpose this study was evaluate therapeutic potential BLT1 antagonist for cigarette smoke (CS)-induced COPD and explore underlying mechanism.In vitro, autophagy proteins were determined by Western blotting RAW264.7 macrophages treated with U75302 (BLT1 antagonist) or inhibitor extract-induced inflammation. In vivo, C57BL/6J mice...